Advances in NSP13 helicase inhibitors for broad-spectrum anti-coronavirus therapy
NSP13 helicase is a promising target for broad-spectrum anti-coronavirus drugs, with recent progress in inhibitor development.
Therapeutic Area
Therapeutic area intelligence for Coronavirus with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.